老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inhibrx Biosciences

87.08
-3.4500-3.81%
盘后：86.92-0.1600-0.18%18:27 EDT
成交量：27.13万
成交额：2,387.28万
市值：12.78亿
市盈率：-9.81
高：92.46
开：90.11
低：85.80
收：90.53
52周最高：155.29
52周最低：28.16
股本：1,467.12万
流通股本：858.89万
量比：1.50
换手率：3.16%
股息：- -
股息率：- -
每股收益(TTM):-8.8768
每股收益(LYR):-9.0434
净资产收益率：-1773.60%
总资产收益率：-43.61%
市净率：-24.12
市盈率(LYR):-9.63

数据加载中...

总览公司新闻资讯公告
2021/05/13

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/12

重要事件披露

8-K - Current report
2021/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/13

重要事件披露

8-K - Current report
2021/01/05

重要事件披露

8-K - Current report
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

重要事件披露

8-K - Current report
2020/11/12

重要事件披露

8-K - Current report
2020/09/11

重要事件披露

8-K - Current report
2020/08/31

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/21

重要事件披露

8-K - Current report
更多